Garner Health has raised $118 million in Series D funding, bringing its total capital to approximately $200 million and valuing the company at $1.35 billion. The round was led by Kleiner Perkins, with participation from Redpoint, Maverick, Kaiser Permanente Ventures, Mercy, Plus Capital and other existing investors.
The New York–based company focuses on evaluating and ranking in-network physicians using large-scale claims analytics and outcomes data. It partners with employers to guide employees toward high-performing doctors, aligning benefit design and financial incentives with provider quality. Garner also works directly with health plans to power provider rankings, directories and network strategies built on performance data rather than reputation or proximity alone.
Central to its model is a dataset comprising more than 60 billion medical records from 320 million patients, sourced from health plans and hospitals. The company argues that variation in physician performance remains one of the largest and least addressed drivers of cost and quality disparities in U.S. healthcare.
“The single most important health decision we make is which individual doctor we see when we need care,” said Nick Reber, founder and CEO of Garner Health. “Our data shows that the top-performing doctors have 75% lower rates of complications and mortality than their peers. By identifying these providers and creating the financial incentives for patients to see them, we aren't just saving money – we're fundamentally re-engineering the healthcare marketplace to reward quality.”
Garner plans to use the new funding to expand and enhance its analytics platform and grow its workforce as demand increases among self-insured employers and payer partners seeking measurable improvements in outcomes and cost control.
The company’s earlier financing includes a strategic investment from Optum Ventures in 2021, alongside a $45 million Series B round that brought total funding at the time to $65 million. Garner also raised $12.5 million in Series A financing and $4.5 million in seed funding, positioning it for its current growth phase as data-driven provider selection becomes a more central lever in value-based care strategies.
Click here for the original news story.